Perioperative Systemic Therapy for Isolated Resectable Colorectal Peritoneal Metastases

ABSTRACT: This is a multicentre, open-label, parallel-group, phase II-III, superiority study that randomises patients with isolated resectable colorectal peritoneal metastases in a 1:1 ratio to receive either perioperative systemic therapy and cytoreductive surgery with HIPEC (experimental arm) or upfront cytoreductive surgery with HIPEC alone (control arm).

DISEASE(S): Colorectal Adenocarcinoma,Colorectal Neoplasm,Carcinoma,Colorectal Cancer,Colorectal Cancer With Isolated Peritoneal Metastases,Peritoneal Carcinomatosis,Neoplasms,Current Condition As Of 11/01/2019: isolated Resectable Colorectal Peritoneal Metastases previous Condition: colorectal Cancer With Isolated Peritoneal Metastases,Isolated Resectable Colorectal Peritoneal Metastases.,Peritoneal Metastases,Colorectal Carcinoma,Peritoneal Cancer,Peritoneal Neoplasms,Peritoneal Neoplasm Malignant Secondary,Neoplasm Metastasis,Geïsoleerde Resectabele Colorectale Peritoneale Metastasen.,Colorectal Neoplasms Malignant,Peritoneal Neoplasm Malignant Secondary Carcinomatosis,Colorectal Neoplasms

PROVIDER: 2214131 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR